3(d) or Not 3(d): That Is the Question Delhi HC Refuses to Answer – For Now
Daewoong Pharmaceutical challenged the Controller's rejection of its crystalline SGLT inhibitor patent before the Delhi High Court. The core question: does improved dissolution and stability satisfy the Section…